XO Score Platform Expansion
Small/Distal Peripheral Vasculature (CLI)
Key Facts
About Transit Scientific
Transit Scientific is a privately held, revenue-generating medical device company focused on the vascular intervention market. Its core technology, protected by a robust intellectual property portfolio (14 patents issued/allowed, 14 pending), enhances the performance of standard angioplasty balloons and provides superior catheter support in complex anatomies. The company has achieved regulatory clearance in the US and EU for its two primary platforms, which address significant unmet needs in treating PAD, CLI, and dialysis access stenosis. With a patient-first mentality and a focus on clinical efficacy, Transit Scientific is positioned to capture share in the large and growing peripheral vascular device market.
View full company profile